Turkish assessment of SURF (SUrvey of Risk Factor Management) study: Control rates of cardiovascular risk factors derived from databases of 15 different levels of health centers in Turkey

Basit Öğe Kaydı
dc.authoridBozkurt Cakir, Irem/0000-0003-2190-516X
dc.authoridTekin, Murat/0000-0001-6841-3045
dc.contributor.authorTokgozoglu, Lale
dc.contributor.authorOguz, Aytekin
dc.contributor.authorBalci, Mustafa Kemal
dc.contributor.authorTemizhan, Ahmet
dc.contributor.authorAltunoglu, Esma Guldal
dc.contributor.authorBektas, Osman
dc.contributor.authorAslan, Guler
dc.date.accessioned2025-01-27T20:57:41Z
dc.date.available2025-01-27T20:57:41Z
dc.date.issued2017
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractObjective: The aim of this study was to evaluate the adherence to recommendations for secondary prevention and the achievement of treatment targets for the control of risk factors in patients with established coronary heart disease (CHD) who were followed-up at various healthcare facilities in Turkey. Methods: According to the protocol of the international Survey of Risk Factor Management study, questionnaire forms were completed and demographic, anthropometric, and laboratory data of CHD patients who were followed-up at a total of 15 selected primary, secondary, and tertiary healthcare centers were recorded. Results: Among a total of 724 CHD patients (69.8% male; mean age: 63.3 +/- 10.7 years) included in the study, 18.4% were current smokers, only 19.1% had normal body mass index, and 22.1% had waist circumference below the limit of abdominal obesity. Physical activity was insufficient in 53% of the patients, 47.3% had low high-density lipoprotein cholesterol value, 46% had triglyceride level above 150 mg/dL, and 67% had glycated hemoglobin value of 6.5% or above. Of all the patients, 88.1% were using antiplatelet drugs, 71.4% were using beta-blockers, 55.7% were using statins, and 41.9% were using angiotensin-converting enzyme inhibitors/angiotensin receptor blockers. Blood pressure was under control in 56.7% of the hypertensive patients using antihypertensive drugs, and the proportion of diabetic patients who reached glycemic control targets using antidiabetic drugs was 35.9%. Low-density lipoprotein cholesterol was below 70 mg/dL in 12.2% of the patients using statins. Conclusion: According to the data obtained, among Turkish CHD patients, the control rate of cardiovascular risk factors is low, and implementation of the recommendations regarding lifestyle modification and medication use for secondary prevention in the current guidelines are insufficient.
dc.identifier.doi10.5543/tkda.2017.39032
dc.identifier.endpage407
dc.identifier.issn1016-5169
dc.identifier.issn1308-4488
dc.identifier.issue5
dc.identifier.pmid28694393
dc.identifier.scopus2-s2.0-85028335672
dc.identifier.scopusqualityQ3
dc.identifier.startpage398
dc.identifier.urihttps://doi.org/10.5543/tkda.2017.39032
dc.identifier.urihttps://hdl.handle.net/20.500.12428/26437
dc.identifier.volume45
dc.identifier.wosWOS:000411505100003
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherKare Publ
dc.relation.ispartofTurk Kardiyoloji Dernegi Arsivi-Archives of The Turkish Society of Cardiology
dc.relation.publicationcategoryinfo:eu-repo/semantics/openAccess
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20250125
dc.subjectCardiovascular disease
dc.subjectquestionnaire
dc.subjectrisk factors
dc.subjectsecondary prevention
dc.titleTurkish assessment of SURF (SUrvey of Risk Factor Management) study: Control rates of cardiovascular risk factors derived from databases of 15 different levels of health centers in Turkey
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu